Radioimmunotherapy of hematological cancer: problems and progress.
Jurcic
J G
JG
Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Scheinberg
D A
DA
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007553:Isotope Labeling / Q000379:methods; D007938:Leukemia / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy*; D018365:Neoplasm, Residual; D016499:Radioimmunotherapy / Q000379:methods / Q000639:trends*; D011879:Radiotherapy Dosage
D000911:Antibodies, Monoclonal